Mechanism

mTOR (mammalian target of rapamycin) via FKBP12

Assets acting on this target.

Class
mTOR inhibitor delivered via drug-coated balloon angioplasty catheter (sirolimus/Rapamune)
Pathway
Binds FKBP12 to form a complex that inhibits mTORC1, arresting the cell cycle and suppressing vascular smooth muscle cell proliferation to prevent restenosis after angioplasty
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets